InsiderFlow

David Scott Moore

CRVS

David Scott Moore serves as director at Corvus Pharmaceuticals, Inc. (CRVS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$250.2K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$250.2K

Companies Traded

1

CRVS

Active Period

Jun 2026

1 total trades

Most Recent

Buy CRVS

Jun 15, 2026 · $250.2K

David Scott Moore's Insider Trading at Corvus Pharmaceuticals, Inc. (CRVS)

Buys

1 · $250.2K

Sells

0 · $0.00

Total Shares Bought

21,700

Total Shares Sold

0

CRVS Price Chart
Loading chart...
DateTypeValue
Jun 15, 2026 Buy$250.2K